Mitchell P. Kopin 13D and 13G filings for :
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-01-29 06:31 am Unchanged |
2020-12-31 | 13G | TNF Pharmaceuticals, Inc. TNFA |
Mitchell P. Kopin | 24,324 7.500% |
0 (Unchanged) |
Filing |
| 2021-01-29 06:19 am Purchase |
2020-12-31 | 13G | BioLineRx Ltd. BLRX |
Mitchell P. Kopin | 478,322 5.200% |
478,322 (New Position) |
Filing |
| 2020-11-20 4:06 pm Purchase |
2020-11-17 | 13G | TNF Pharmaceuticals, Inc. TNFA |
Mitchell P. Kopin | 24,324 7.500% |
24,321 (+748340.00%) |
Filing |
| 2020-05-26 06:23 am Unchanged |
2020-05-14 | 13G | TNF Pharmaceuticals, Inc. TNFA |
Mitchell P. Kopin | 3 0.003% |
0 (Unchanged) |
Filing |